The only problem with this stock is the patients with no insurance. If they get rid of this problem, SSY should go back to the $10-$12 PS range. The bottom line improvement may take a year but the value will be factored in much earlier than this.
The main problem appears to be MANAGEMENT!!They had a buyout opportunity several years ago at roughly$10/share----now look at share price!!The acquisition of the specialty pharmacy group now appeare to be a mistake.Our only hope now appears to be a buyout with a Group who can run the business for a profit.
Absolutely agree about management comment - they seem to treat this co. as their personal piggybank. Its their lifestyle company - in the meantime shareholders like us get screwed. There are a couple of new players out there helping hospitals solve their collections problems but ofcourse, Bob Thornton is too busy for managing our company.